Newsfeeds Archive - Page 9 of 194

1 minute read

Genmab, AbbVie On Saturday Announced New Pivotal Data for Bispecific Antibody Epcoritamab CD3xCD20) Demonstrates High Overall and Complete Responses in Patients with Hard-To-Treat Relapsed/Refractory Follicular Lymphoma

December 9, 4:21 PM

Genmab A/S (NASDAQ:GMAB) and AbbVie (NYSE:ABBV) today announced new data from the ongoing phase 1/2 EPCORE™ NHL-1 clinical trial investigating epcoritamab (DuoBody ® CD3xCD20), a T-cell engaging bispecific

ABBV

1 minute read

Events
News

Cogent Biosciences Announced Initial Data from Phase 2 SUMMIT Trial Evaluating Bezuclastinib In Patients with Nonadvanced Systemic Mastocytosis 57% Median Best Improvement On MC-QoL And 78% Of Patients Reporting ≥1 Point Improvement On PGIS By Week 20

By Charles Gross

December 9, 4:16 PM

Cogent Biosciences, Inc. (NASDAQ:COGT), a biotechnology company focused on developing precision therapies for genetically defined diseases, today reported positive initial data from the Company’s ongoing Phase

COGT

1 minute read

M&A
News

Aspen Global To Acquire The Entire Share Capital Of Its Subsidiary, Sandoz (China) Pharmaceutical Co. With Commercialization Rights And Related Intellectual Property For A Portfolio Of Established Products

By Charles Gross

December 4, 7:10 AM

Aspen Pharmacare Holdings Limited, a global multinational specialty pharmaceutical company, has announced that Aspen Global Incorporated (“AGI”), its wholly owned subsidiary incorporated in Mauritius, has

NVS

1 minute read

News

Alterity Therapeutics Announced Sunday, Efficacy Data for ATH434 In A Primate Model Of Parkinson’s Disease; Said ATH434 Improved Motor Performance And General Function

By Charles Gross

December 4, 5:54 AM

Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today

ATHE

1 minute read

Mesoblast Announced Sunday Placement And Accelerated Non-renounceable Entitlement Offer To Raise Up To A$97M

By Charles Gross

December 4, 5:51 AM

Mesoblast Limited ((ASX:MSB, NASDAQ:MESO) today announced a placement and entitlement offer to raise up to A$97.0 million. Key Highlights The Placement and Entitlement Offer has been structured as: • an

MESO

1 minute read

News

Immuron Announced Earlier First Patients Enrolled In Campylobacter Challenge Clinical Study

By Charles Gross

December 4, 5:47 AM

Immuron Limited ((ASX: IMC, NASDAQ:IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to announce that the US Naval Medical Research Command (NMRC) has initiated the clinical

IMRN

1 minute read

News
Tech

Advanced Health Intelligence Reported Earlier, It Will Launch Medically Approved Mobile Phone-Based Atrial Fibrillation Assessment Q2 2024

By Charles Gross

November 30, 6:17 AM

Advanced Health Intelligence Ltd (ASX: AHI) (NASDAQ:AHI) (“AHI” or the “Company”) would like to inform shareholders that the Company will be expanding the current biometric assessment suite with

AHI

1 minute read

News

Clarivate And The Chinese Academy Of Sciences Released Annual Report To Identify 128 Research Fronts

By Charles Gross

November 28, 7:14 AM

Clarivate Plc (NYSE:CLVT), a global leader in connecting people and organizations to intelligence they can trust to transform their world, and the Chinese Academy of Sciences (CAS) today

CLVT

1 minute read

News

Alterity Therapeutics Earlier Announced Presentation Of Novel Biomarker Data For Evaluation Of Multiple System Atrophy

By Charles Gross

November 27, 6:17 AM

Alterity Therapeutics ((ASX: ATH, NASDAQ:ATHE) (“Alterity” or “the Company”), a biotechnology company dedicated to developing disease modifying treatmentsfor neurodegenerative diseases, today

ATHE

1 minute read

Faraday Future Announced Entry Into Middle East, Signed Strategic Cooperation Agreements With Master Investment Group aAd Siraj Holding LLC,; Unveiled FF 91 2.0 Futurist aiFalcon Limited Edition For Middle East Market

By Charles Gross

November 23, 4:34 PM

Faraday Future Intelligent Electric Inc. (NASDAQ:FFIE) (“Faraday Future”, “FF” or “Company”), a California-based global shared intelligent electric mobility ecosystem company, today

FFIE